Select Asset Management & Trust’s AbbVie ABBV Stock Holding History

Select Asset Management & Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.41M	Hold	6,500	–	–	0.44%	23
2025 Q4	$1.49M	Hold	6,500	–	–	0.46%	24
2025 Q3	$1.5M	Hold	6,500	–	–	0.46%	26
2025 Q2	$1.21M	Buy	6,500 +500	+8%	+$92.9K	0.41%	27
2025 Q1	$1.26M	Hold	6,000	–	–	0.5%	24
2024 Q4	$1.07M	Buy	+6,000	New	+$1.1M	0.41%	27

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Select Asset Management & Trust's ABBV Position: Q1 2026 in Review

Select Asset Management & Trust held its AbbVie (ABBV) position steady in Q1 2026 at 6,500 shares worth $1.41M. The position accounts for 0.44% of the portfolio, ranked #23.

Select Asset Management & Trust first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.5M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Select Asset Management & Trust held 6,500 shares of AbbVie worth $1.41M as of Q1 2026.
Select Asset Management & Trust left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.44% of Select Asset Management & Trust's portfolio in Q1 2026, its #23 holding.
Select Asset Management & Trust first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
Select Asset Management & Trust's AbbVie position peaked at $1.5M in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Select Asset Management & Trust's 13F filing for Q1 2026, filed 15 May 2026.